-
761
-
762
-
763
NTHi killing activity is reduced in COPD patients and is associated with a differential microbiome
Published 2025-01-01Get full text
Article -
764
-
765
-
766
-
767
-
768
Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms
Published 2025-01-01Get full text
Article -
769
-
770
-
771
-
772
The TB27 Transcriptomic Model for Predicting Mycobacterium tuberculosis Culture Conversion
Published 2025-01-01Get full text
Article -
773
Evaluating Adherence to Antiretroviral Therapy Using Pharmacy Refill Records in a Rural Treatment Site in South Africa
Published 2017-01-01“…Logistic regression was also performed to determine the relationship between adherence and virologic suppression and the adherence threshold resulting in <10% virologic failure. …”
Get full text
Article -
774
Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality
Published 2011-01-01“…To define the long-term (2–4 years) clinical and virological outcome of an antiretroviral treatment (ART) programme in rural South Africa. …”
Get full text
Article -
775
Comparison of Expectant and Excisional/Ablative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in the Era of HPV Testing
Published 2022-01-01“…Among 175 (52.9%) patients initially managed conservatively, 77.3% (133/172) regressed, 13.4% (23/172) persisted, 9.3% (16/172) progressed to CIN3+, and 97 (56.4%) patients achieved virological regression. 156 (47.1%) patients underwent initial excision/ablation, with an 89.4% (110/123) virological cure rate. …”
Get full text
Article -
776
-
777
Restoration of Innate and Adaptive Immune Responses by HCV Viral Inhibition with an Induction Approach Using Natural Interferon-Beta in Chronic Hepatitis C
Published 2012-01-01“…IL-15 was increased at the end of induction therapy in both early virologic responders (EAVRs) and late virologic responders (LAVRs); CXCL-8, CXCL-10, and CCL-4 levels were significantly decreased (𝑃<0.05) in EAVR but not in LAVR during NCT, and IL-12 increased significantly (𝑃<0.05) and CXCL-8 decreased significantly (𝑃<0.05) after the end of NCT in EAVR but not in LAVR. …”
Get full text
Article -
778
Comparative Effectiveness of Darunavir 1,200 mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients
Published 2013-01-01“…The primary outcome of virologic suppression was defined as <50 copies/mL at 24 weeks. …”
Get full text
Article -
779
Ocular manifestations and treatment safety in hepatitis C patients undergoing direct-acting antiviral therapy: a prospective cohort study
Published 2025-02-01“…All patients achieved sustained virological response, and a notable improvement in fibrosis degree post-treatment was observed. …”
Get full text
Article -
780
Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy
Published 2019-01-01“…Overall sustained virologic response (SVR) rate was 81% and 86% in intent-to-treat (ITT) and modified ITT analysis, respectively (74% and 78% in virologic failures, 92% and 100% in nonvirologic failures). …”
Get full text
Article